Skip to main
LPSN
LPSN logo

LivePerson (LPSN) Stock Forecast & Price Target

LivePerson (LPSN) Analyst Ratings

Based on 31 analyst ratings
Buy
Strong Buy 39%
Buy 19%
Hold 39%
Sell 3%
Strong Sell 0%

Bulls say

LivePerson Inc. demonstrates a positive outlook through its improved financial metrics, particularly an adjusted EBITDA of $0.5 million, which reflects a year-over-year increase of $1.8 million and a margin of 0.6%, surpassing initial estimates. Additionally, the company's gross margins expanded significantly by 361 basis points year-over-year, reaching 69.7%, although slightly under the forecast. The contribution of approximately $7 million from Wild Health-related Medicare reimbursement revenue during Q3 further bolsters its financial position, aligning with management's prior guidance and suggesting momentum in operational transformation efforts.

Bears say

LivePerson Inc. is experiencing a significant decline in revenue, with guidance for 2Q24 indicating a drop of 20% year-over-year to between $76.0 million and $80.0 million, falling short of consensus estimates. The company's 2024 revenue outlook projects total revenues of $300 million to $315 million, representing a decline of 22%, which is also below consensus expectations, highlighting increasing customer cancellations and a growing trend of contraction in both hosted and professional services revenues. Overall, the consistent underperformance against market expectations and the substantial negative revenue growth trajectory raise concerns about the company's future financial stability.

LivePerson (LPSN) has been analyzed by 31 analysts, with a consensus rating of Buy. 39% of analysts recommend a Strong Buy, 19% recommend Buy, 39% suggest Holding, 3% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of LivePerson and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About LivePerson (LPSN) Forecast

Analysts have given LivePerson (LPSN) a Buy based on their latest research and market trends.

According to 31 analysts, LivePerson (LPSN) has a Buy consensus rating as of Jul 1, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $26.13, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $26.13, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

LivePerson (LPSN)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.